<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28076627</article-id><article-id pub-id-type="pmc">5407142</article-id><article-id pub-id-type="doi">10.5935/1678-9741.20160093</article-id><article-categories><subj-group subj-group-type="heading"><subject>Experimental Work</subject></subj-group></article-categories><title-group><article-title>PetCO<sub>2</sub>, VCO<sub>2</sub> and CorPP Values in the Successful
Prediction of the Return of Spontaneous Circulation: An Experimental Study on
Unassisted Induced Cardiopulmonary Arrest</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Macedo</surname><given-names>Ana Carolina Longui</given-names></name><degrees>MSc</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Martins</surname><given-names>Luiz Claudio</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Paschoal</surname><given-names>Ilma Aparecida</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ovalle</surname><given-names>Carlos Cesar Ivo Sant'Ana</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Ara&#x000fa;jo</surname><given-names>Sebasti&#x000e3;o</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Moreira</surname><given-names>Marcos Mello</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1"><label>1</label> Universidade Estadual de Campinas (UNICAMP), Campinas,
SP, Brazil.</aff><aff id="aff2"><label>2</label> Universidade Paulista, S&#x000e3;o Paulo, SP,
Brazil.</aff><author-notes><corresp id="c1">Correspondence Address: Marcos Mello Moreira, Universidade Estadual
de Campinas - Cidade Universit&#x000e1;ria "Zeferino Vaz", R. Tess&#x000e1;lia Vieira de
Camargo, 126, Campinas, SP, Brazil - Zip code: 13083-887. E-mail:
<email>marcosmm@fcm.unicamp.br</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Nov-Dec</season><year>2016</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Nov-Dec</season><year>2016</year></pub-date><volume>31</volume><issue>6</issue><fpage>468</fpage><lpage>473</lpage><history><date date-type="received"><day>24</day><month>6</month><year>2016</year></date><date date-type="accepted"><day>19</day><month>9</month><year>2016</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><title>Abstract</title><sec><title>Introduction</title><p>During cardiac arrest, end-tidal CO<sub>2</sub> (PetCO<sub>2</sub>),
VCO<sub>2</sub> and coronary perfusion pressure fall abruptly and tend
to return to normal levels after an effective return of spontaneous
circulation. Therefore, the monitoring of PetCO<sub>2</sub> and
VCO<sub>2</sub> by capnography is a useful tool during clinical
management of cardiac arrest patients.</p></sec><sec><title>Objective</title><p>To assess if PetCO<sub>2</sub>, VCO<sub>2</sub> and coronary perfusion
pressure are useful for the prediction of return of spontaneous circulation
in an animal model of cardiac arrest/cardiopulmonary resuscitation treated
with vasopressor agents.</p></sec><sec><title>Methods</title><p>42 swine were mechanically ventilated (FiO<sub>2</sub>=0.21). Ventricular
fibrillation was induced and, after 10 min, unassisted cardiac arrest was
initiated, followed by compressions. After 2 min of basic cardiopulmonary
resuscitation, each group received: Adrenaline, Saline-Placebo, Terlipressin
or Terlipressin + Adrenaline. Two minutes later (4<sup>th</sup> min of
cardiopulmonary resuscitation), the animals were defibrillated and the ones
that survived were observed for an additional 30 min period. The variables
of interest were recorded at the baseline period, 10 min of ventricular
fibrillation, 2<sup>nd</sup> min of cardiopulmonary resuscitation,
4<sup>th</sup> min of cardiopulmonary resuscitation, and 30 min after
return of spontaneous circulation.</p></sec><sec><title>Results</title><p>PetCO<sub>2</sub> and VCO<sub>2</sub> values, both recorded at 2 min and 4
min of cardiopulmonary resuscitation, have no correlation with the return of
spontaneous circulation rates in any group. On the other hand, higher values
of coronary perfusion pressure at the 4th min of cardiopulmonary
resuscitation have been associated with increased return of spontaneous
circulation rates in the adrenaline and adrenaline + terlipressin
groups.</p></sec><sec><title>Conclusion</title><p>Although higher values of coronary perfusion pressure at the 4th min of
cardiopulmonary resuscitation have been associated with increased return of
spontaneous circulation rates in the animals that received adrenaline or
adrenaline + terlipressin, PetCO<sub>2</sub> and VCO<sub>2</sub> have not
been shown to be useful for predicting return of spontaneous circulation
rates in this porcine model.</p></sec></abstract><kwd-group><kwd>Heart Arrest</kwd><kwd>Induced</kwd><kwd>Cardiopulmonary Resuscitation</kwd><kwd>Capnography</kwd><kwd>Epinephrine</kwd></kwd-group><funding-group><award-group><funding-source>FAPESP</funding-source><award-id>07/08315-0</award-id></award-group><award-group><funding-source>FAEPEX</funding-source><award-id>17809</award-id></award-group></funding-group></article-meta></front><body><table-wrap id="t5" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup width="50%" span="1"><col span="1"/><col span="1"/></colgroup><thead><tr style="background-color:#e6e7e8"><th colspan="2" rowspan="1"><bold>Abbreviations, acronyms &#x00026; symbols</bold></th></tr></thead><tbody><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">ADR</td><td align="left" rowspan="1" colspan="1">=Adrenaline</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">AHA</td><td align="left" rowspan="1" colspan="1">=American Heart Association</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">CA</td><td align="left" rowspan="1" colspan="1">=Cardiac arrest</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">CorPP</td><td align="left" rowspan="1" colspan="1">=Coronary perfusion pressure</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">CPR</td><td align="left" rowspan="1" colspan="1">=Cardiopulmonary resuscitation</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">DC</td><td align="left" rowspan="1" colspan="1">=Decreased cardiac output</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">IMV</td><td align="left" rowspan="1" colspan="1">=Invasive mechanical ventilation</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">PetCO<sup>2</sup></td><td align="left" rowspan="1" colspan="1">=End-tidal CO<sub>2</sub></td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">ROSC</td><td align="left" rowspan="1" colspan="1">=Return of spontaneous circulation</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">TP</td><td align="left" rowspan="1" colspan="1">=Terlipressin</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">VF</td><td align="left" rowspan="1" colspan="1">=Ventricular fibrillation</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">V/Q</td><td align="left" rowspan="1" colspan="1">=Ventilation/perfusion ratio</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Cardiac arrests occur daily in large numbers in several countries of the world and,
for the most part, result in death. Cardiopulmonary resuscitation (CPR) is proposed
by the American Heart Association (AHA) as an easy intervention, with the goal of
reducing the number of deaths, despite discouraging statistics showing that only a
small number of patients survive after this event. The use of methods that assess
the effectiveness of CPR and that are preferably non-invasive, indicating the
metabolic state and the dynamics of the cardiovascular system, would be of great
value. Essentially, CPR consists of manual compressions of the patient's thorax, in
an effort to help create an artificial anterograde blood flow, combined with either
a noninvasive ventilation technique (<italic>e.g</italic>., mouth-to-mouth) or
invasive mechanical ventilation in order to oxygenate the blood that reaches the
lungs<sup>[</sup><sup><xref rid="r1" ref-type="bibr">1</xref></sup><sup>]</sup>.</p><p>Capnography presents itself as a non-invasive method, applicable at the bedside, that
allows for the assessment of cardiorespiratory status both in experimental<sup><xref rid="r2" ref-type="bibr">2</xref></sup><sup>-</sup><sup><xref rid="r6" ref-type="bibr">6</xref></sup><sup>]</sup> and clinical
studies<sup>[</sup><sup><xref rid="r7" ref-type="bibr">7</xref></sup><sup>-</sup><sup><xref rid="r12" ref-type="bibr">12</xref></sup><sup>]</sup>. In addition, it is considered an indicator and/or
guide for decisions that enables the assessment of the quality of the CPR
maneuvers<sup>[</sup><sup><xref rid="r13" ref-type="bibr">13</xref></sup><sup>]</sup>. Capnography evaluates and monitors physiological
conditions by measuring exhaled CO<sub>2</sub> through an infrared light sensor.
CO<sub>2</sub> excretion (VCO<sub>2</sub>) and partial pressure of
CO<sub>2</sub> at the end of the exhalation (PetCO<sub>2</sub>) are indicative
of O<sub>2</sub> consumption by the oxidative metabolism in the tissues and those
values are closely related to the pulmonary ventilation/perfusion ratio (V/Q);
hence, it is expected that both will increase in an effective CPR. Therefore, the
monitoring of exhaled CO<sub>2</sub> has been proposed and used as a non-invasive
method to assess cardiorespiratory function, especially in situations of decreased
cardiac output (DC), such as during shock and CPR, and its use is compulsory in
Surgical Centers<sup>[</sup><sup><xref rid="r14" ref-type="bibr">14</xref></sup><sup>]</sup>.</p><p>Capnography has been regarded as a potentially useful monitoring method in evaluating
the effectiveness of CPR maneuvers, despite limitations and controversies
surrounding the subject<sup>[</sup><sup><xref rid="r15" ref-type="bibr">15</xref></sup><sup>]</sup>. Animal and human studies have shown a good
correlation between PetCO<sub>2</sub> and DC during stages of decreased blood flow
and during CPR<sup>[</sup><sup><xref rid="r16" ref-type="bibr">16</xref></sup><sup>]</sup>. PetCO<sub>2</sub> can reflect the pulmonary blood
flow generated in CPR if CO<sub>2</sub> production and alveolar ventilation are
relatively constant during resuscitation maneuvers; however, it is difficult to be
measured when CPR is stopped because of changes in the alveolar dead space and
minute volume ratio, which affects the correlation between PetCO<sub>2</sub> and
DC<sup>[</sup><sup><xref rid="r17" ref-type="bibr">17</xref></sup><sup>]</sup>.</p><p>Some studies suggest that the increase in PetCO<sub>2</sub> during CA is a predictor
of the success of the CPR. Considering the event of cardiac arrest, CPR and the
post-event, we can find several changes in PetCO<sub>2</sub> levels. It is known
that the values of PetCO<sub>2</sub> at the beginning of ventricular fibrillation
(VF) fall significantly, and this reduction is attributed to decreased pulmonary
blood flow, which is insufficient to carry and eliminate the CO<sub>2</sub> produced
in the tissues. Evidently, in extreme cases of low DC, there would also be a lower
CO<sub>2</sub> production because of the anaerobic metabolism, given the low
O<sub>2</sub> supply to the tissues. Once CPR is started, and it is effective in
oxygenating the blood and increasing the tissue flow, PetCO<sub>2</sub> values also
increase, as an increase in blood flow must occur in the pulmonary capillaries,
which in turn results in the exhalation of CO<sub>2</sub>. When the return of
spontaneous circulation (ROSC) occurs, those values increase significantly, reaching
levels comparable to those before CA. These changes are useful to quantify the
effectiveness and success of the CPR maneuvers as well as to assess the
cardiorespiratory status of the patient after ROSC. It has been observed that there
is no survival for a PetCO<sub>2</sub> &#x0003c; 5 mmHg<sup>[</sup><sup><xref rid="r18" ref-type="bibr">18</xref></sup><sup>]</sup>.</p><p>Some studies have mentioned a few factors that can affect the levels of
CO<sub>2</sub> eliminated by expiration. Among them, we can mention alveolar
ventilation, DC, the area of distribution of blood flow in the body, and the
production of CO<sub>2</sub> by tissues. Some authors also reported that the
measurement of CO<sub>2</sub> is not able to reflect the certain success of CPR,
since the results do not confirm those reported in studies that have measured other
parameters<sup>[</sup><sup><xref rid="r19" ref-type="bibr">19</xref></sup><sup>]</sup>. However, capnography is still used and regarded as
the best and most effective non-invasive method of measuring the elimination of
CO<sub>2</sub> in Emergency Rooms, Surgery Centers, and ICU in cases of CA,
being considered essential when performing CPR, for decision-making, assessment of
its initial success (ROSC), and subsequent clinical evolution (cardiorespiratory
stabilization).</p><p>The objective of this study was to assess if PetCO<sub>2</sub>, VCO<sub>2</sub>, and
coronary perfusion pressure (CorPP) values are useful in predicting the success of
ROSC in an animal model of CA/CPR using vasopressor agents.</p></sec><sec sec-type="methods"><title>METHODS</title><p>This study was approved by the Institutional Review Committee for Experiments with
Animals (EAEC-IB-Unicamp-1276-1/2007) and it was conducted in the laboratory of
Experimental Surgery and Medicine, School of Medical Sciences - Universidade
Estadual de Campinas (UNICAMP), S&#x000e3;o Paulo, Brazil.</p><p>The methods used were the same as the ones described in the novel article of Ovalle
et al.<sup>[</sup><sup><xref rid="r20" ref-type="bibr">20</xref></sup><sup>]</sup>,
using forty-two Large-White, immature swine, weighing approximately 20 kg, which
presented ROSC. Under anesthesia with ketamine (10 mg.kg<sup>-1</sup>
intramuscularly) and thiopental (25 mg.kg<sup>-1</sup> intravenously), the animals
were intubated endotracheally and ventilated with FiO<sub>2</sub>=0.21 (and positive
pressure at the end of exhalation of 0 cmH2O), a fixed respiratory rate (10 cpm),
and a tidal volume ranging from 15 to 20 mL/kg (Ventilator
DX-3010<sup>&#x000ae;</sup>, Dixtal, Brazil), in order to maintain a
PetCO<sub>2</sub> between 36-44 mmHg (Respiratory Profile Monitor
CO<sub>2</sub>SMO Plus 8100<sup>&#x000ae;</sup>, Dixtal/Novametrix, Respironics,
Murrisville, PA, USA). Surgical vascular catheterizations were performed to measure
pressure in the thoracic aorta and the right atrium (DX-2020<sup>&#x000ae;</sup>,
Dixtal, Brazil).</p><p>Using a bipolar pacemaker placed on the right ventricular cavity, we induced VF,
which remained without assistance for 10 minutes. Then, the animals were kept in the
supine position and reattached to the mechanical ventilator, and we started CPR (100
compressions/10 ventilations/min, continuously, without alternating with chest
compressions).</p><p>After two minutes, the animals were allocated into four groups (randomized and
blind), receiving via central IV: Group 1 - Adrenaline (ADR - 45
&#x000b5;g.kg<sup>-1</sup>); Group 2 - saline-placebo (10 ml); Group 3 -
Terlipressin (TP* - *Glypressin<sup>&#x000ae;</sup>, Laborat&#x000f3;rios Ferring
Ltda., Brazil - 20 &#x000b5;g.kg<sup>-1</sup>); and Group 4 - TP (20
&#x000b5;g.kg<sup>-1</sup>) + ADR (45 &#x000b5;g.kg<sup>-1</sup>). All drugs were
diluted in saline solution (10 ml), in equal syringes, thus the main resuscitator
did not know what drug was being administered.</p><p>Two minutes after injecting the drugs, defibrillation was performed with sequential
shocks (every 15 seconds) of 200 J (Biphasic Defibrillator, Cardiomax, Instramed,
Brazil), until ROSC, a pace other than VF was obtained or 2 minutes of attempts had
elapsed. We set the return of spontaneous circulation as the recovery of spontaneous
heart rate with a systolic blood pressure &#x02265; 60 mmHg for &#x02265; 5 minutes.
The animals were considered as survivors when they remained alive, with a systolic
blood pressure &#x02265; 60 mmHg, without the use of additional vasopressor agents
for 30 minutes after ROSC.</p><p>During spontaneous circulation, CorPP was calculated as the difference between mean
arterial pressure and mean central venous pressure. During CPR maneuvers, CorPP was
calculated as diastolic arterial pressure (decompression) minus central venous
pressure (decompression)<sup>[</sup><sup><xref rid="r21" ref-type="bibr">21</xref></sup><sup>]</sup>. At the completion of the experiment, all animals
resurrected were killed with an overdose of thiopental and 19.1% potassium
chloride.</p><sec><title>Statistical Analysis</title><p>Initially, we performed a descriptive analysis, presented in the form of tables
with frequency and measures of the location and dispersion of values. For
comparison of the parameters assessed in only one moment between the groups, we
used the Kruskal-Wallis test. For comparison of the parameters measured among
the groups and times, we used the analysis of variance (ANOVA) for repeated
measures, with transformation by posts, followed by multiple comparisons through
the Tukey test for the location of differences between groups and the profile
test for contrasts for the location of the differences between times. To verify
the difference between proportions, we used Fisher's exact test. Statistical
tests were bilateral and the significance level adopted was 5%
(<italic>P</italic>&#x0003c;0.05).</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>In <xref ref-type="table" rid="t1">Table 1</xref>, we describe the values of the
following variables:</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p> Descriptive analysis and comparisons of the variables assessed at baseline
(0), 2 min of CPR (2), and 4 min of CPR (4) within and among groups.</p></caption><table frame="hsides" rules="all"><colgroup width="16%" span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1"><bold>ADR + TP (n=11)</bold></th><th align="center" rowspan="1" colspan="1"><bold>ADR (n=10)</bold></th><th align="center" rowspan="1" colspan="1"><bold>Placebo (n=10)</bold></th><th align="center" rowspan="1" colspan="1"><bold>TP (n=11)</bold></th><th align="center" rowspan="1" colspan="1"><bold><italic>P</italic></bold></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">PetCO<sub>2</sub> 0<xref ref-type="table-fn" rid="TFN2">*</xref></td><td align="center" rowspan="1" colspan="1">42.5&#x000b1;5.2</td><td align="center" rowspan="1" colspan="1">39.4+3.5</td><td align="center" rowspan="1" colspan="1">43.4+3.5</td><td align="center" rowspan="1" colspan="1">40.4+6</td><td align="center" rowspan="1" colspan="1"><xref ref-type="table-fn" rid="TFN2">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">VCO<sub>2</sub> 0<xref ref-type="table-fn" rid="TFN3">&#x000a5;</xref></td><td align="center" rowspan="1" colspan="1">121.2+20.5</td><td align="center" rowspan="1" colspan="1">133.4+53.7</td><td align="center" rowspan="1" colspan="1">110.2+21.2</td><td align="center" rowspan="1" colspan="1">119.3+40.8</td><td align="center" rowspan="1" colspan="1">&#x000a5;</td></tr><tr><td align="left" rowspan="1" colspan="1">CorPP 0<xref ref-type="table-fn" rid="TFN4">&#x000a7;</xref>
</td><td align="center" rowspan="1" colspan="1">88.9&#x000b1;21</td><td align="center" rowspan="1" colspan="1">89.7+19.5</td><td align="center" rowspan="1" colspan="1">91.0+18.3</td><td align="center" rowspan="1" colspan="1">85.5+23.2</td><td align="center" rowspan="1" colspan="1"><xref ref-type="table-fn" rid="TFN4">&#x000a7;</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">PetCO<sub>2</sub> 2<xref ref-type="table-fn" rid="TFN2">*</xref></td><td align="center" rowspan="1" colspan="1">50.7+13.1</td><td align="center" rowspan="1" colspan="1">37.4+14</td><td align="center" rowspan="1" colspan="1">43.4+16.3</td><td align="center" rowspan="1" colspan="1">44.2+17.7</td><td align="center" rowspan="1" colspan="1"><xref ref-type="table-fn" rid="TFN2">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">VCO<sub>2</sub> 2<xref ref-type="table-fn" rid="TFN3">&#x000a5;</xref></td><td align="center" rowspan="1" colspan="1">48.7&#x000b1;27.5</td><td align="center" rowspan="1" colspan="1">57.5+30.2</td><td align="center" rowspan="1" colspan="1">47.5+21.2</td><td align="center" rowspan="1" colspan="1">45.3+24.5</td><td align="center" rowspan="1" colspan="1">&#x000a5;</td></tr><tr><td align="left" rowspan="1" colspan="1">CorPP 2<xref ref-type="table-fn" rid="TFN4">&#x000a7;</xref>
</td><td align="center" rowspan="1" colspan="1">21.3+10.4</td><td align="center" rowspan="1" colspan="1">12.6+12.1</td><td align="center" rowspan="1" colspan="1">22.7+13.5</td><td align="center" rowspan="1" colspan="1">20.2+15.5</td><td align="center" rowspan="1" colspan="1"><xref ref-type="table-fn" rid="TFN4">&#x000a7;</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">PetCO<sub>2</sub> 4<xref ref-type="table-fn" rid="TFN2">*</xref></td><td align="center" rowspan="1" colspan="1">44.3+15</td><td align="center" rowspan="1" colspan="1">43.6+19.3</td><td align="center" rowspan="1" colspan="1">46.3+12.4</td><td align="center" rowspan="1" colspan="1">51.0+19.4</td><td align="center" rowspan="1" colspan="1"><xref ref-type="table-fn" rid="TFN2">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">VCO<sub>2</sub> 4<xref ref-type="table-fn" rid="TFN3">&#x000a5;</xref></td><td align="center" rowspan="1" colspan="1">46.4+31.1</td><td align="center" rowspan="1" colspan="1">49.6+32.9</td><td align="center" rowspan="1" colspan="1">49.2+21.3</td><td align="center" rowspan="1" colspan="1">35.5+25.5</td><td align="center" rowspan="1" colspan="1">&#x000a5;</td></tr><tr><td align="left" rowspan="1" colspan="1">CorPP 4<xref ref-type="table-fn" rid="TFN4">&#x000a7;</xref>
</td><td align="center" rowspan="1" colspan="1">44.6+13.1</td><td align="center" rowspan="1" colspan="1">53.1+15.2</td><td align="center" rowspan="1" colspan="1">13.7+12</td><td align="center" rowspan="1" colspan="1">7.0+10.5</td><td align="center" rowspan="1" colspan="1"><xref ref-type="table-fn" rid="TFN4">&#x000a7;</xref>
</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>ADR=adrenaline; TP=terlipressin; PetCO<sub>2</sub>=end-tidal carbon
dioxide tension (mmHg); VCO<sub>2</sub>=carbon dioxide excretion;
CorPP=coronary perfusion pressure</p></fn><fn id="TFN2"><label>*</label><p>Results of the ANOVA for repeated measurements with transformation for
posts:</p><p> Effect of group, P=0.5427; effect of time, P=0.1317; group/time
interaction, P=0.3043.</p></fn><fn id="TFN3"><label>&#x000a5;</label><p>Results of the ANOVA for repeated measurements with transformation for
posts:</p><p> Effect of group, P=0.7530; effect of time, P=&#x0003c;0.0001; group/time
interaction, P=0.8622.</p><p>Differences between times (profile test for contrast):</p><p> Basal' 2'CPR, <italic>P</italic>&#x0003c;0.0001; basal' 4'CPR,
<italic>P</italic>&#x0003c;0.0001; 2'CPR' 4'CPR, P=0.2286.</p></fn><fn id="TFN4"><label>&#x000a7;</label><p>Results of the ANOVA for repeated measurements with transformation for
posts:</p><p>Effect of group, P=0.0012; effect of time, <italic>P</italic>&#x0003c;0.0001;
group/time interaction, <italic>P</italic>&#x0003c;0.0001.</p><p> Fixed group and time comparison (profile test for contrast):</p><p>Placebo group, <italic>P</italic>&#x0003c;0.0001; Basal &#x02194; 2'CPR,
<italic>P</italic>&#x0003c;0.0001; basal &#x02194; 4'CPR,
<italic>P</italic>&#x0003c;0.0001; 2'CPR &#x02194; 4'CPR, P=0.06.</p><p>Adrenaline group, <italic>P</italic>&#x0003c;0.0001; Basal &#x02194; 2'CPR,
<italic>P</italic>&#x0003c;0.0001; Basal &#x02194; 4'CPR,
<italic>P</italic>&#x0003c;0.0014; 2'CPR &#x02194; 4'CPR,
<italic>P</italic>&#x0003c;0.0001.</p><p>Terlipressin group, <italic>P</italic>&#x0003c;0.0001; Basal &#x02194; 2'CPR,
<italic>P</italic>&#x0003c;0.0001; Basal &#x02194; 4'CPR,
<italic>P</italic>&#x0003c;0.0001; 2'CPR &#x02194; 4'CPR, P=0.0072.</p><p> ADR+TP group, <italic>P</italic>&#x0003c;0.0001; Basal &#x02194; 2'CPR,
<italic>P</italic>&#x0003c;0.0001; Basal &#x02194; 4'CPR, P=0.0003; 2'CPR &#x02194;
4'CPR, <italic>P</italic>&#x0003c;0.0001.</p><p> Setting time and comparing groups (Tukey test):</p><p> Basal, without differences, P=0.9369; 2'CPR, without differences,
P=0.2341; 4'CPR, with differences in Placebo and Adrenaline;</p><p> Adrenaline and Terlipressin; ADR+TP and Placebo; Terlipressin and
ADR+TP, <italic>P</italic>&#x0003c;0.0001.</p></fn></table-wrap-foot></table-wrap><p>
<list list-type="bullet"><list-item><p>PetCO<sub>2</sub> (mmHg) measured at baseline (before induction of CA),
two minutes of CPR (before the injection of drugs), and 4 min of CPR (2
min after the injection of drugs and immediately before ventricular
defibrillation); there were no statistically significant differences
between the groups;</p></list-item><list-item><p>VCO<sub>2</sub> (mL/min) measured at baseline (before induction of CA),
two minutes of CPR (before the injection of drugs), and 4 min of CPR (2
min after the injection of drugs and immediately before ventricular
defibrillation); although there was a statistically significant decrease
in VCO<sub>2</sub> at 2 min and 4 min of CPR in relation to baseline,
there were no statistically significant differences between the groups
at any moment;</p></list-item><list-item><p>CorPP (mmHg) measured at baseline (before induction of CA), two minutes
of CPR (before the injection of drugs), and 4 min of CPR (2 min after
the injection of drugs and immediately before ventricular
defibrillation). A statistically significant increase in CorPP between
the 2 min of CPR (before the injection of drugs) and 4 min of CPR (2 min
after the injection of drugs) was observed in the ADR and ADR+TP groups
compared to the placebo and isolated TP groups (which was equal to
placebo);</p></list-item><list-item><p>Baseline rectal temperature (&#x000ba;C): ADR: 39.0&#x000b1;0.7; Placebo:
39&#x000b1;0.5; TP: 39.3&#x000b1;0.6; and ADR+TP: 39.6&#x000b1;0.4
(<italic>P</italic>=0.2085).</p></list-item></list>
</p><p>Those same variables are shown in <xref ref-type="fig" rid="f01">Figures 1</xref>,
<xref ref-type="fig" rid="f02">2</xref> and <xref ref-type="fig" rid="f03">3</xref>.</p><p>
<fig id="f01" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Comparative evolution of the variables assessed at baseline (0), 2 min of
CPR (2) and 4 min of CPR in the groups studied. Average value and
standard deviation of PetCO<sub>2</sub> in each moment and group.</p></caption><graphic xlink:href="rbccv-31-06-0468-g01"/></fig>
<fig id="f02" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Comparative evolution of the variables assessed at baseline (0), 2 min of
CPR (2) and 4 min of CPR in the groups studied. Average value and
standard deviation of VCO<sub>2</sub> in each moment and group.</p></caption><graphic xlink:href="rbccv-31-06-0468-g02"/></fig>
<fig id="f03" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Comparative evolution of the variables assessed at baseline (0), 2 min of
CPR (2) and 4 min of CPR in the groups studied. Average value and
standard deviation of CorPP in each moment and group.</p></caption><graphic xlink:href="rbccv-31-06-0468-g03"/></fig>
</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Several studies, both clinical and trial, have investigated the prognostic value of
capnography in CA/CPR. The PetCO<sub>2</sub> measured by capnography in intubated
patients has been correlated with the quality of CPR maneuvers and with ROSC,
considering that it is directly related to DC, which in turn is directly related to
pulmonary blood flow, PetCO<sub>2</sub> being its reflection<sup>[</sup><sup><xref rid="r22" ref-type="bibr">22</xref></sup><sup>]</sup>. However, no
experimental model under invasive mechanical ventilation (IMV), with PEEP=0
cmH<sub>2</sub>O and FiO<sub>2</sub>=0.21, has assessed PetCO<sub>2</sub>,
VCO<sub>2</sub>, and CorPP in the prediction of success of ROSC on unassisted
CPR for 10 min using terlipressin (a pro-drug, a vasopressin synthetic analogue,
with a longer half-life than vasopressin), adrenaline and their combination as
vasopressor agents, in addition to placebo.</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Descriptive analysis and comparison of the percentage of survivors among the
groups.</p></caption><table frame="hsides" rules="all"><colgroup width="16%" span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1"><bold>Surviving groups</bold></th><th align="center" rowspan="1" colspan="1"><bold>ADR+TP (n=11)</bold></th><th align="center" rowspan="1" colspan="1"><bold>ADR (n=10)</bold></th><th align="center" rowspan="1" colspan="1"><bold>Placebo (n=10)</bold></th><th align="center" rowspan="1" colspan="1"><bold>TP (n=11)</bold></th><th align="center" rowspan="1" colspan="1"><bold>Total (n=42)</bold></th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">No n (%)</td><td align="center" rowspan="1" colspan="1">2 (18)</td><td align="center" rowspan="1" colspan="1">2 (20)</td><td align="center" rowspan="1" colspan="1">8 (80)</td><td align="center" rowspan="1" colspan="1">10 (91)</td><td align="center" rowspan="1" colspan="1">22 (52)</td></tr><tr><td align="center" rowspan="1" colspan="1">Yes n (%)</td><td align="center" rowspan="1" colspan="1">9 (82)</td><td align="center" rowspan="1" colspan="1">8 (80)</td><td align="center" rowspan="1" colspan="1">2 (20)</td><td align="center" rowspan="1" colspan="1">1 (9)</td><td align="center" rowspan="1" colspan="1">20 (48)</td></tr></tbody></table><table-wrap-foot><fn id="TFN5"><p><italic>P</italic>&#x0003c;0.0001 (Fisher's test)</p></fn></table-wrap-foot></table-wrap><p>In several published studies, PetCO<sub>2</sub> has proved to be a useful variable in
assessing the effectiveness of CPR maneuvers and results in different models of
CA.</p><p>In the 1980s, Sanders et al.<sup>[</sup><sup><xref rid="r23" ref-type="bibr">23</xref></sup><sup>]</sup> monitored the elimination of CO<sub>2</sub>
(VCO<sub>2</sub>) in experimental studies of CA/CPR. The elimination of
CO<sub>2</sub> was assessed in different types of chest compression, and the
study reported that all types of maneuvers increased PetCO<sub>2</sub>. Little more
than a decade later, Blumenthal et al.<sup>[</sup><sup><xref rid="r24" ref-type="bibr">24</xref></sup><sup>]</sup>, also in an experimental study,
measured PetCO<sub>2</sub> and VCO<sub>2</sub> and concluded that higher values of
PetCO<sub>2</sub> during and after CPR were associated with a better
prognosis.</p><p>In our study, there was no statistically significant association between the times
and the registered values for PetCO<sub>2</sub> with ROSC, although a sudden and
immediate increase in PetCO<sub>2</sub> at the beginning of the CPR was observed,
which expresses the pulmonary blood flow, and thus, DC. The data indicates that
PetCO<sub>2</sub>, both at 2 min and 4 min of CPR (more importantly, because it
was after the administration of the drugs), is not correlated with ROSC rates,
<italic>i.e</italic>., it was not different among the four groups. Nevertheless,
we have to consider that in our study the CA/CPR model was performed on very young
(immature) animals, being an extreme CA model, for 10 min without any assistance,
and, after this period, the animals were ventilated with an initial FiO<sub>2</sub>
(0.21). We should also highlight the fact that we did not alternate between
ventilation and compression, which may have compromised the effectiveness of the
alveolar ventilation.</p><p>In relation to VCO<sub>2</sub> at 2 and 4 min of CPR, it did not differ statistically
between the four groups and, therefore, it was not indicative of ROSC. On the other
hand, CorPP proved to be significantly higher in the ADR and ADR+TP groups compared
to the Placebo and Terlipressin groups at 4 minutes of CPR, which indicates that
CorPP was a predictive factor for ROSC.</p><p>Human studies use other variables to assess the successful prediction of ROSC.
Different criteria are used, but capnography is also the main focus of the
prognostic assessment after CA. One of the first studies in the 1980s by Garnett et
al.<sup>[</sup><sup><xref rid="r25" ref-type="bibr">25</xref></sup><sup>]</sup>
assessed patients under IMV who presented CA, and they concluded that the monitoring
of PetCO<sub>2</sub> during CPR can be useful and serve as a guide during
resuscitation maneuvers.</p><p>Another clinical study, conducted by Sanders et al.<sup>[</sup><sup><xref rid="r26" ref-type="bibr">26</xref></sup><sup>]</sup>, assessed
PetCO<sub>2</sub> in patients subjected to CPR. The authors reported that all
patients listed and those who presented ROSC showed an average PetCO<sub>2</sub>
&#x02265; 10 mmHg. None of the patients with an average PetCO<sub>2</sub> &#x02264; 10
mmHg presented ROSC. The data in this prospective clinical test indicate that the
monitoring of PetCO<sub>2</sub> during CPR can be useful in the prediction of ROSC
in CPR in humans.</p><p>PetCO<sub>2</sub> values have been correlated with CorPP and ROSC rate. Thus, in an
animal model (dogs) of CA/CPR, Sanders et al.<sup>[</sup><sup><xref rid="r27" ref-type="bibr">27</xref></sup><sup>]</sup>, in another study, found a significant
correlation (<italic>P</italic>&#x0003c;0.01) between PetCO<sub>2</sub> and CorPP. The
data in this study were confirmed by the same group, in the same year, with small
variations in the method. However, the actual physiological relationship between
CorPP and PetCO<sub>2</sub> during CPR remains uncertain<sup>[</sup><sup><xref rid="r23" ref-type="bibr">23</xref></sup><sup>]</sup>.</p><p>In our study, we have observed a significant increase in CorPP
(<italic>P</italic>&#x0003c;0.0001) in the 4<sup>th</sup> minute of CPR (after drugs) in
relation to the 2<sup>nd</sup> min (before drugs) of CPR in the ADR and ADR+TP
groups. However, the same behavior was no observed in PetCO<sub>2</sub> and
VCO<sub>2</sub>.</p><p>The use of vasopressor agents is suggested in the first cycles of
CPR<sup>[</sup><sup><xref rid="r25" ref-type="bibr">25</xref></sup><sup>]</sup>. For different types of CA, vasopressor, adrenaline
or vasopressin can be administered in order to increase myocardial and cerebral
blood flow. In the study of Ovalle et al.<sup>[</sup><sup><xref rid="r20" ref-type="bibr">20</xref></sup><sup>]</sup>, the use of some vasopressor agents
during CPR was assessed. It was observed that ADR and its combination with
terlipressin, but not isolated terlipressin, were effective in increasing CorPP and
ROSC. Furthermore, the ADR+TP combination provided greater hemodynamic stability
after ROSC in the surviving animals, suggesting that TP can be a useful drug in
handling hypotension after CPR<sup>[</sup><sup><xref rid="r28" ref-type="bibr">28</xref></sup><sup>]</sup>.</p><p>In most published studies, both clinical and experimental ones, the initial, final,
maximum and minimum readings show higher values of PetCO<sub>2</sub> in patients who
presented ROSC. These authors highlight that clinical studies receive influences
from diseases already present in patients, and this factor should be
considered<sup>[</sup><sup><xref rid="r18" ref-type="bibr">18</xref></sup><sup>]</sup>.</p><p>The PetCO<sub>2</sub> values assessed in many (clinical and experimental) studies can
assist in verifying the effectiveness of CPR maneuvers in order to guide, with due
caution, the actual results of resuscitation, since very low PetCO<sub>2</sub>
values may indicate that there is no more reason to continue the efforts of
CPR<sup>[</sup><sup><xref rid="r29" ref-type="bibr">29</xref></sup><sup>]</sup>.</p><p>In short, PetCO<sub>2</sub> and VCO<sub>2</sub> values obtained by volumetric
capnography have differed from the findings in some published studies. In addition,
those values are not correlated with hemodynamic variables (CorPP) or with ROSC
rates in our experimental model with immature swine, in which CA was induced by
ventricular fibrillation and the animals remained without assistance for 10 min with
subsequent CPR. It should be noted that the animals were under IMV, with
FiO<sub>2</sub>=0.21 and PEEP=0 cmH<sub>2</sub>O, and we used vasopressor agents
(ADR and TP; isolated or in association).</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>From the results obtained in the study, both PetCO<sub>2</sub> and VCO<sub>2</sub>
showed no correlation with ROSC, although VCO<sub>2</sub> was 50% lower during the
CPR maneuvers (would it be more sensitive in the detection of a decrease in
pulmonary blood flow?). Although we cannot affirm with certainty, some hypotheses
were made to explain this fact, namely: FiO<sub>2</sub>=0.21 during the entire
experiment, immaturity of the animals, time of non-assistance after CA (10 minutes),
and positive pressure (IMV) in the CPR, which may have led to an even sharper
decrease in the right preload. Thus, further studies are needed to verify the value
of volumetric capnography (PetCO<sub>2</sub> and VCO<sub>2</sub>) to guide the
effectiveness of CPR maneuvers, especially with the use of adjuvant vasopressor
agents.</p><table-wrap id="t6" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup width="50%" span="1"><col span="1"/><col span="1"/></colgroup><thead><tr><th colspan="2" align="left" rowspan="1"><bold>Authors' roles &#x00026;
responsibilities</bold></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">ACLM</td><td align="left" rowspan="1" colspan="1">Analysis and/or data interpretation; manuscript writing
or critical review of its content; final manuscript approval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LCM</td><td align="left" rowspan="1" colspan="1">Analysis and/or data interpretation; manuscript writing
or critical review of its content; final manuscript approval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IAP</td><td align="left" rowspan="1" colspan="1">Analysis and/or data interpretation; manuscript writing
or critical review of its content; final manuscript approval;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CCISO</td><td align="left" rowspan="1" colspan="1">Conception and design study; realization of operations
and/ or trials; analysis and/or data interpretation; manuscript
writing or critical review of its content</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SA</td><td align="left" rowspan="1" colspan="1">Conception and study design; execution of operations
and/ or trials; analysis and/or data interpretation; manuscript
writing or critical review of its content; final manuscript
approval;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MMM</td><td align="left" rowspan="1" colspan="1">Execution of operations and/or trials; analysis and/or
data interpretation; manuscript writing or critical review of its
content; final manuscript approval</td></tr></tbody></table></table-wrap></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>We are grateful to Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de S&#x000e3;o Paulo (Fapesp)
(process N&#x000ba;. 07/08315-0) and to Fundo de Apoio ao Ensino, Pesquisa e Extens&#x000e3;o
(Faepex)-Unicamp (process N&#x000ba; 17809) for their financial support; to Ferring
Laboratories-Brazil-Ltda, for their kind donation of two 1 mg terlipressin vials for
the pilot studies; to the biologists Ana C. Moraes and William A. Silva, from N&#x000fa;cleo
de Medicina e Cirurgia Experimental-FCM-Unicamp, for their technical assistance
during experimental procedures; and to the statisticians from the Research
Commission-FCM-Unicamp, for their technical assistance during data analysis.</p><p>The authors also thank Espa&#x000e7;o da Escrita - General Coordination of the University -
UNICAMP - for the language services provided.</p></ack><fn-group><fn fn-type="other"><p>This study was carried out at Universidade Estadual de Campinas (UNICAMP),
Campinas, SP, Brazil.</p></fn><fn fn-type="supported-by"><p>This study was funded by the S&#x000e3;o Paulo Research Foundation (FAPESP), process N&#x000ba;
07/08315-0, and the Teaching, Research and Extension Support Fund (FAEPEX),
UNICAMP, process N&#x000ba; 17809.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gravenstein</surname><given-names>JS</given-names></name><name><surname>Jaffe</surname><given-names>M</given-names></name><name><surname>Paulus</surname><given-names>DA</given-names></name></person-group><source>Capnography:clinical aspects. Carbon dioxide over time and
volume</source><comment>Second edition</comment><year>2011</year><publisher-loc>Cambridge</publisher-loc><publisher-name>Cambridge University Press</publisher-name></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toneloto</surname><given-names>MG</given-names></name><name><surname>Moreira</surname><given-names>MM</given-names></name><name><surname>Bustorff-Silva</surname><given-names>JM</given-names></name><name><surname>Souza</surname><given-names>GF</given-names></name><name><surname>Martins</surname><given-names>LC</given-names></name><name><surname>Dragosavac</surname><given-names>D</given-names></name><etal/></person-group><article-title>Adjustable inspiratory occlusion valve in experimental
bronchopleural fistula. A new therapeutic perspective</article-title><source>Acta Cir Bras</source><year>2015</year><volume>30</volume><issue>8</issue><fpage>561</fpage><lpage>567</lpage><pub-id pub-id-type="pmid">26352336</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antonelli</surname><given-names>RQ</given-names></name><name><surname>Moreira</surname><given-names>MM</given-names></name><name><surname>Martins</surname><given-names>LC</given-names></name><name><surname>Negro</surname><given-names>MS</given-names></name><name><surname>Baldasso</surname><given-names>TA</given-names></name><name><surname>Tincani</surname><given-names>AJ</given-names></name></person-group><article-title>Evaluation of the efficiency of the atraumatic endotracheal tube
in the pulmonary-gas exchange: an experimental study</article-title><source>Braz J Cardiovasc Surg</source><year>2015</year><volume>30</volume><issue>6</issue><fpage>668</fpage><lpage>672</lpage><pub-id pub-id-type="pmid">26934410</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>DG</given-names></name><name><surname>Toneloto</surname><given-names>MG</given-names></name><name><surname>Moreira</surname><given-names>MM</given-names></name><name><surname>Bustorff-Silva</surname><given-names>JM</given-names></name><name><surname>Souza</surname><given-names>GF</given-names></name><name><surname>Martins</surname><given-names>LC</given-names></name><etal/></person-group><article-title>Hemodynamic, ventilatory and gasometric evaluation of an
experimental bronchopleural fistula</article-title><source>Acta Cir Bras</source><year>2015</year><volume>30</volume><issue>1</issue><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">25627265</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>DJ</given-names></name><name><surname>Moreira</surname><given-names>MM</given-names></name><name><surname>Paschoal</surname><given-names>IA</given-names></name><name><surname>Martins</surname><given-names>LC</given-names></name><name><surname>Metze</surname><given-names>K</given-names></name><name><surname>Moreno</surname><given-names>H</given-names><suffix>Junior</suffix></name></person-group><article-title>Near-fatal pulmonary embolism in an experimental model:
hemodynamic, gasometric and capnographic variables</article-title><source>Rev Bras Cir Cardiovasc</source><year>2011</year><volume>26</volume><issue>3</issue><fpage>462</fpage><lpage>468</lpage><pub-id pub-id-type="pmid">22086585</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreira</surname><given-names>JH</given-names></name><name><surname>Terzi</surname><given-names>RG</given-names></name><name><surname>Paschoal</surname><given-names>IA</given-names></name><name><surname>Silva</surname><given-names>WA</given-names></name><name><surname>Moraes</surname><given-names>AC</given-names></name><name><surname>Moreira</surname><given-names>MM</given-names></name></person-group><article-title>Mechanisms underlying gas exchange alterations in an experimental
model of pulmonary embolism</article-title><source>Braz J Med Biol Res</source><year>2006</year><volume>39</volume><issue>9</issue><fpage>1197</fpage><lpage>1204</lpage><pub-id pub-id-type="pmid">16981047</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>SM</given-names></name><name><surname>Paschoal</surname><given-names>IA</given-names></name><name><surname>De Capitani</surname><given-names>EM</given-names></name><name><surname>Moreira</surname><given-names>MM</given-names></name><name><surname>Palhares</surname><given-names>LC</given-names></name><name><surname>Pereira</surname><given-names>MC</given-names></name></person-group><article-title>COPD phenotypes on computed tomography and its correlation with
selected lung function variables in severe patients</article-title><source>Int J Chron Obstruct Pulmon Dis</source><year>2016</year><volume>11</volume><fpage>503</fpage><lpage>513</lpage><pub-id pub-id-type="pmid">27042039</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>PM</given-names></name><name><surname>Moreira</surname><given-names>MM</given-names></name></person-group><article-title>Capnography: a feasible tool in clinical and experimental
settings</article-title><source>Respir Care</source><year>2015</year><volume>60</volume><issue>11</issue><fpage>1711</fpage><lpage>1713</lpage><pub-id pub-id-type="pmid">26493596</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veronez</surname><given-names>L</given-names></name><name><surname>Pereira</surname><given-names>MC</given-names></name><name><surname>Silva</surname><given-names>SM</given-names></name><name><surname>Barcaui</surname><given-names>LA</given-names></name><name><surname>De Capitani</surname><given-names>EM</given-names></name><name><surname>Moreira</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Volumetric capnography for the evaluation of chronic airways
diseases</article-title><source>Int J Chron Obstruct Pulmon Dis</source><year>2014</year><volume>23</volume><issue>9</issue><fpage>983</fpage><lpage>989</lpage></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro</surname><given-names>MA</given-names></name><name><surname>Silva</surname><given-names>MT</given-names></name><name><surname>Ribeiro</surname><given-names>JD</given-names></name><name><surname>Moreira</surname><given-names>MM</given-names></name><name><surname>Almeida</surname><given-names>CC</given-names></name><name><surname>Almeida-Junior</surname><given-names>AA</given-names></name><etal/></person-group><article-title>Volumetric capnography as a tool to detect early peripheral lung
obstruction in cystic fibrosis patients</article-title><source>J Pediatr (Rio J)</source><year>2012</year><volume>88</volume><issue>6</issue><fpage>509</fpage><lpage>517</lpage><pub-id pub-id-type="pmid">23269106</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veronez</surname><given-names>L</given-names></name><name><surname>Moreira</surname><given-names>MM</given-names></name><name><surname>Soares</surname><given-names>ST</given-names></name><name><surname>Pereira</surname><given-names>MC</given-names></name><name><surname>Ribeiro</surname><given-names>MA</given-names></name><name><surname>Ribeiro</surname><given-names>JD</given-names></name><etal/></person-group><article-title>Volumetric capnography for the evaluation of pulmonary disease in
adult patients with cystic fibrosis and noncystic fibrosis
bronchiectasis</article-title><source>Lung</source><year>2010</year><volume>188</volume><issue>3</issue><fpage>263</fpage><lpage>268</lpage><pub-id pub-id-type="pmid">20049470</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreira</surname><given-names>MM</given-names></name><name><surname>Terzi</surname><given-names>RG</given-names></name><name><surname>Paschoal</surname><given-names>IA</given-names></name><name><surname>Martins</surname><given-names>LC</given-names></name><name><surname>Oliveira</surname><given-names>EP</given-names></name><name><surname>Falc&#x000e3;o</surname><given-names>AL</given-names></name></person-group><article-title>Thrombolysis in massive pulmonary embolism based on the
volumetric capnography</article-title><source>Arq Bras Cardiol</source><year>2010</year><volume>95</volume><issue>4</issue><fpage>e97</fpage><lpage>e99</lpage><pub-id pub-id-type="pmid">21180783</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Welch</surname><given-names>A</given-names></name></person-group><source>Capnography, mainstream and sidestream modules</source><publisher-loc>Beaverton</publisher-loc><year>2003</year></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blumenthal</surname><given-names>SR</given-names></name><name><surname>Voorhess</surname><given-names>WD</given-names></name></person-group><article-title>The relationship between airway carbon dioxide excretion and
cardiac output during cardiopulmonary resuscitation</article-title><source>Resuscitation</source><year>1997</year><volume>34</volume><issue>3</issue><fpage>263</fpage><lpage>270</lpage><pub-id pub-id-type="pmid">9178388</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalenda</surname><given-names>Z</given-names></name></person-group><article-title>The capnogram as a guide to the efficacy of cardiac
massage</article-title><source>Resuscitation</source><year>1978</year><volume>6</volume><issue>4</issue><fpage>259</fpage><lpage>263</lpage><pub-id pub-id-type="pmid">755268</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreira</surname><given-names>MM</given-names></name><name><surname>Terzi</surname><given-names>RGG</given-names></name><name><surname>Ferreira</surname><given-names>ELA</given-names></name><name><surname>Moraes</surname><given-names>AC</given-names></name><name><surname>Silva</surname><given-names>WA</given-names></name></person-group><article-title>Correla&#x000e7;&#x000e3;o entre a press&#x000e3;o
expirat&#x000f3;ria final de CO2 e o d&#x000e9;bito card&#x000ed;aco no choque
hemorr&#x000e1;gico experimental</article-title><source>RBTI</source><year>2005</year><volume>17</volume><issue>3</issue><fpage>188</fpage><lpage>113</lpage></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sehra</surname><given-names>R</given-names></name><name><surname>Underwood</surname><given-names>K</given-names></name><name><surname>Checchia</surname><given-names>P</given-names></name></person-group><article-title>End tidal CO2 is a quantitative measure of cardiac
arrest</article-title><source>Pacing Clin Electrophysiol</source><year>2003</year><volume>26</volume><issue>1</issue><issue-part>Pt 2</issue-part><fpage>515</fpage><lpage>517</lpage><pub-id pub-id-type="pmid">12687881</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blumenthal</surname><given-names>SR</given-names></name><name><surname>Voorhess</surname><given-names>WD</given-names></name></person-group><article-title>The relationship between airway carbon dioxide excretion and
cardiac output during cardiopulmonary resuscitation</article-title><source>Resuscitation</source><year>1997</year><volume>34</volume><issue>3</issue><fpage>263</fpage><lpage>270</lpage><pub-id pub-id-type="pmid">9178388</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asplin</surname><given-names>BR</given-names></name><name><surname>White</surname><given-names>RD</given-names></name></person-group><article-title>Prognostic value of end-tidal carbon dioxide pressures during
out-of-hospital cardiac arrest</article-title><source>Ann Emerg Med</source><year>1995</year><volume>25</volume><issue>6</issue><fpage>756</fpage><lpage>761</lpage><pub-id pub-id-type="pmid">7755196</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ovalle</surname><given-names>CCIS</given-names></name><name><surname>Moreira</surname><given-names>MM</given-names></name><name><surname>Martins</surname><given-names>LC</given-names></name><name><surname>Araujo</surname><given-names>S</given-names></name></person-group><article-title>A efic&#x000e1;cia da terlipressina versus adrenalina na
ressuscita&#x000e7;&#x000e3;o cardiopulmonar em su&#x000ed;nos</article-title><source>Rev Bras Anestesiol</source><year>2011</year><volume>61</volume><issue>6</issue><fpage>728</fpage><lpage>735</lpage><pub-id pub-id-type="pmid">22063374</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paradis</surname><given-names>NA</given-names></name><name><surname>Martin</surname><given-names>GB</given-names></name><name><surname>Rivers</surname><given-names>EP</given-names></name><name><surname>Goetting</surname><given-names>MG</given-names></name><name><surname>Appleton</surname><given-names>TJ</given-names></name><name><surname>Feingold</surname><given-names>M</given-names></name><etal/></person-group><article-title>Coronary perfusion pressure and the return of spontaneous
circulation in human cardiopulmonary resuscitation</article-title><source>JAMA</source><year>1990</year><volume>263</volume><issue>8</issue><fpage>1106</fpage><lpage>1113</lpage><pub-id pub-id-type="pmid">2386557</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gudipati</surname><given-names>CV</given-names></name><name><surname>Weil</surname><given-names>MH</given-names></name><name><surname>Bisera</surname><given-names>J</given-names></name><name><surname>Deshmukh</surname><given-names>HG</given-names></name><name><surname>Rackow</surname><given-names>EC</given-names></name></person-group><article-title>Expired carbon dioxide: a noninvasive monitor of cardiopulmonary
resuscitation</article-title><source>Circulation</source><year>1988</year><volume>77</volume><issue>1</issue><fpage>234</fpage><lpage>239</lpage><pub-id pub-id-type="pmid">3121209</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>AB</given-names></name><name><surname>Ewy</surname><given-names>GA</given-names></name><name><surname>Bragg</surname><given-names>S</given-names></name><name><surname>Atlas</surname><given-names>M</given-names></name><name><surname>Kern</surname><given-names>KB</given-names></name></person-group><article-title>Expired PCO2 as a prognostic indicator of successful
resuscitation from cardiac arrest</article-title><source>Ann Emerg Med</source><year>1985</year><volume>14</volume><issue>10</issue><fpage>948</fpage><lpage>952</lpage><pub-id pub-id-type="pmid">3929653</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blumenthal</surname><given-names>SR</given-names></name><name><surname>Voorhees</surname><given-names>WD</given-names></name></person-group><article-title>The relationship of carbon dioxide excretion during
cardiopulmonary resuscitation to regional blood flow and
survival</article-title><source>Resuscitation</source><year>1997</year><volume>35</volume><issue>2</issue><fpage>135</fpage><lpage>143</lpage><pub-id pub-id-type="pmid">9316197</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garnett</surname><given-names>AR</given-names></name><name><surname>Ornato</surname><given-names>JP</given-names></name><name><surname>Gonzalez</surname><given-names>ER</given-names></name><name><surname>Johnson</surname><given-names>EB</given-names></name></person-group><article-title>End-tidal carbon dioxide monitoring during cardiopulmonary
resuscitation</article-title><source>JAMA</source><year>1987</year><volume>257</volume><issue>4</issue><fpage>512</fpage><lpage>515</lpage><pub-id pub-id-type="pmid">3098993</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>AB</given-names></name><name><surname>Kern</surname><given-names>KB</given-names></name><name><surname>Otto</surname><given-names>CW</given-names></name><name><surname>Milander</surname><given-names>MM</given-names></name><name><surname>Ewy</surname><given-names>GA</given-names></name></person-group><article-title>End-tidal carbon dioxide monitoring during cardiopulmonary
resuscitation. A prognostic indicator for survival</article-title><source>JAMA</source><year>1989</year><volume>262</volume><issue>10</issue><fpage>1347</fpage><lpage>1351</lpage><pub-id pub-id-type="pmid">2761035</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>AB</given-names></name><name><surname>Atlas</surname><given-names>M</given-names></name><name><surname>Ewy</surname><given-names>GA</given-names></name><name><surname>Kern</surname><given-names>KB</given-names></name><name><surname>Bragg</surname><given-names>S</given-names></name></person-group><article-title>Expired PCO2 as an index of coronary perfusion
pressure</article-title><source>Am J Emerg Med</source><year>1985</year><volume>3</volume><issue>2</issue><fpage>147</fpage><lpage>149</lpage><pub-id pub-id-type="pmid">3918548</pub-id></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>MM</given-names></name><name><surname>Timerman</surname><given-names>S</given-names></name><name><surname>Gianotto-Oliveira</surname><given-names>R</given-names></name><name><surname>Polastri</surname><given-names>TF</given-names></name><name><surname>Canesin</surname><given-names>MF</given-names></name><name><surname>Schimidt</surname><given-names>A</given-names></name><etal/><collab>Sociedade Brasileira de Cardiologia</collab></person-group><article-title>First guidelines of the Brazilian Society of Cardiology on
Cardiopulmonary Resuscitation and Cardiovascular Emergency
Care</article-title><source>Arq Bras Cardiol</source><year>2013</year><volume>101</volume><issue>2</issue><supplement>Suppl 3</supplement><fpage>1</fpage><lpage>221</lpage></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nordseth</surname><given-names>T</given-names></name><name><surname>Olasveengen</surname><given-names>TM</given-names></name><name><surname>Kvaloy</surname><given-names>JT</given-names></name><name><surname>Wik</surname><given-names>L</given-names></name><name><surname>Steen</surname><given-names>PA</given-names></name><name><surname>Skogvoll</surname><given-names>E</given-names></name></person-group><article-title>Dynamic effects of adrenaline (epinephrine) in out-of-hospital
cardiac arrest with initial pulseless electrical activity
(PEA)</article-title><source>Resuscitation</source><year>2012</year><volume>83</volume><issue>8</issue><fpage>946</fpage><lpage>952</lpage><pub-id pub-id-type="pmid">22429969</pub-id></element-citation></ref></ref-list></back></article>